Volume 30, Issue 1 (March 2026)                   Physiol Pharmacol 2026, 30(1): 10-21 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

A. Ghanimi H, H. Maad A, Omar Khudhur Z, Karimian A, Nahumi A, Asadi A, et al . Gender disparities, environmental pollutants, genetic and epigenetics in autism spectrum disorder: revealing the links. Physiol Pharmacol 2026; 30 (1) :10-21
URL: http://ppj.phypha.ir/article-1-2540-en.html
Abstract:   (1040 Views)

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social interaction, communication challenges, and repetitive behaviors. Its etiology is multifactorial, involving interactions among genetic, epigenetic, and environmental factors. Recent studies have revealed that environmental pollutants, immune dysregulation, mitochondrial dysfunction, oxidative stress, and epigenetic alterations play significant roles in the development of ASD. Exposure to environmental toxins such as heavy metals and air pollutants has been linked to an increased risk of ASD, primarily by inducing oxidative stress, neuroinflammation, and neurotoxicity. Immune dysregulation, marked by abnormal immune responses, may also contribute to neurodevelopmental alterations observed in ASD. Mitochondrial dysfunction, resulting in impaired energy metabolism and elevated oxidative stress, is frequently reported in individuals with ASD. In addition, epigenetic mechanisms such as DNA methylation and histone modifications are crucial for regulating gene expression and can be influenced by environmental exposures. Individuals with ASD exhibit abnormal epigenetic patterns, indicating that environmental factors can influence gene function without modifying the genetic code. The higher prevalence of ASD in males indicates potential sex-specific susceptibilities and points to a complex gene–environment interaction. While genetic predisposition is a major factor, environmental influences may intensify or reduce the risk. Understanding these interconnected mechanisms is vital for developing improved diagnostic tools, early interventions, and effective therapies. Future research should aim to identify specific biomarkers and molecular targets, enabling personalized approaches to ASD management. A deeper understanding of these mechanisms offers promising pathways for prevention, early detection, and treatment of ASD.

Full-Text [PDF 1000 kb]   (22 Downloads)    
Type of Manuscript: Review | Subject: Neurophysiology/Pharmacology

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.